The effectiveness of anticoagulant therapy in COVID-19 associated ischemic stroke

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2998

Full metadata record

DC Field	Value	Language
dc.contributor.author	M. Atanivazov. A. Khamidov	-
dc.date.accessioned	2022-10-11T08:05:20Z	-
dc.date.available	2022-10-11T08:05:20Z	-
dc.date.issued	2022	-
dc.identifier.issn	1468-1331 (202206)29:6+1	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2998	-
dc.description.abstract	Study was aimed to study the effect of various anticoagulant agents used in COVID-19 associated ischemic stroke on hemorheological parameters.	en_US
dc.language.iso	en	en_US
dc.publisher	Австрия, Вена	en_US
dc.relation.ispartofseries	УДК;	-
dc.subject	anticoagulant therapy ,ischemic stroke	en_US
dc.title	The effectiveness of anticoagulant therapy in COVID-19 associated ischemic stroke	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
9. Атаниязов_М_К_халқаро_тезис_2022_июнь.pdf	The effectiveness of anticoagulant therapy in COVID-19 associated ischemic stroke	1.14 MB	Adobe PDF	View/Open

DSpace JSPUI